Documentos de Académico
Documentos de Profesional
Documentos de Cultura
TEXTO COMPLETO
El consumo de cigarrillos y otras formas de uso del tabaco son la Contenido especial
causa de más del 20% de la mortalidad anual. Y esto continúa siendo sobre COVID-19
así a pesar de los importantes esfuerzos que la mayoría de los
fumadores hacen por abandonar su dependencia de la nicotina. Relevancia clínica del
supuesto aumento de la
Ahora sabemos que este aparentemente irracional comportamiento morbilidad cardiovascular
está fuertemente relacionado con la farmacología de la nicotina, con asociada al uso de
inhibidores de la
sus efectos sobre el cerebro, y que los cigarrillos son ciclooxigenasa tipo 2
la Sí
es | en | pt
diabetes mellitus tipo 2
¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos? No
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 1/19
12/4/24, 4:39 Farmacología de la nicotina | Medicina Integral
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 2/19
12/4/24, 4:39 Farmacología de la nicotina | Medicina Integral
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 4/19
12/4/24, 4:39 Farmacología de la nicotina | Medicina Integral
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 5/19
12/4/24, 4:39 Farmacología de la nicotina | Medicina Integral
El receptor nicotínico
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 6/19
12/4/24, 4:39 Farmacología de la nicotina | Medicina Integral
Metabolización y eliminación
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 7/19
12/4/24, 4:39 Farmacología de la nicotina | Medicina Integral
Efectos farmacológicos
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 8/19
12/4/24, 4:39 Farmacología de la nicotina | Medicina Integral
Acciones generales
Otras acciones es | en | pt
¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 9/19
12/4/24, 4:39 Farmacología de la nicotina | Medicina Integral
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 10/19
12/4/24, 4:39 Farmacología de la nicotina | Medicina Integral
Los fumadores presentan una tasa metabólica basal (MB) más alta.
Los fumadores como media pesan menos que los no fumadores y al
abandonar el consumo de tabaco, disminuye su MB y se incrementa
su peso42.
Interacciones
Tolerancia
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 11/19
12/4/24, 4:39 Farmacología de la nicotina | Medicina Integral
Adicción
Síndrome de abstinencia
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 14/19
12/4/24, 4:39 Farmacología de la nicotina | Medicina Integral
Cuestiones pendientes
BIBLIOGRAFÍA
[6] Comorbidity and smoking. Proceeding of the addicted to nicotine. A National Research
Forum. Natcher Conference Center National Institutes of Health; 1998 July 27-28; Bethesda.
Maryland. EE.UU. Disponible en URL:http://www.nida.nih.gov
[8] Tabaco. En: Freixa F , Solor Insa I, eds. Toxicomanías. Un enfoque multidisciplinario (1.a ed).
Barcelona: Editorial Fontanella, SA, 1981; 109-136.
[9] Pharmacology aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988;
319:1.318-1.330.
[10] Cigarette smoking and clinically significant drug interactions. Ann Pharmacotherapy 1995;
29:1.139-1.148.
[11] Nicotine metabolism variability and nicotine addiction. Proceeding of the addicted to
nicotine. A National Research Forum. Natcher Conference Center National Institutes of
Health; 1998 July 27-28; Bethesda. Maryland. EE.UU. Disponible en URL:
http://www.nida.nih.gov/meetsum/nicotine/Nicotine.html
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 16/19
12/4/24, 4:39 Farmacología de la nicotina | Medicina Integral
[13] Review of the evidence that pH ia a determinant of nicotine dosage from oral use of
smokeless tobacco. Tob Control 1997; 6:219-225.
[14] Withdrawal: nicotine (tobacco). En: Jaffe JH, ed. Encyclopedia of drugs and alcohol. New
York-London: Simon & Schuster MacMillan, 1995; 1.282-1.286.
[16] Molecular biology and knockouts of nicotinec receptors. Proceeding of the addicted to
nicotine. A National Research Forum. Natcher Conference Center National Institutes of
Health; 1998 July 27-28; Bethesda. Maryland. EE.UU. Disponible en URL:
http://www.nida.nih.gov/meetsum/nicotine/Nicotine.html
[17] Drug addiction and drug abuse. En: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW,
Gilman AG, eds. Goodman & Gilman's. The pharmacological basis of therapeutics (9.a ed).
New York: McGraw-Hill, 1996; 557-577.
[18] Molecular and cellular aspects of nicotine abuse. Neuron 1996; 16:905-908.
[19] Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family
in excitable cells. J Mol Evol 1995; 40:115-172.
[20] The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.
Psychopharmacol (Berl) 1992; 107:285-289.
[21] Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in
the brain. Nature 1995; 374:65-67.
[25] Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke
[3H] dopamine release from rat striatal slices in a calcium-dependant manner. J Pharmacol
Exp Ther 1999; 288:905-911.
[27] Individual differences in sensitivity to nicotine: implications for genetic research on nicotine
dependence. Behav Genet 1995; 25:161-177.
es | en | pt
[28] ¿Es usted profesional
Fernández-Salguero sanitario
P, Hoffman SM, Cholertonapto para prescribir
S, Mohrenweiser o dispensar
H, Raunio H, Rautio A,medicamentos?
et
al..
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 17/19
12/4/24, 4:39 Farmacología de la nicotina | Medicina Integral
[29] Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 1996;
24:1.212-1.217.
[30] A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol
Exp Ther 1997; 282:1.608-1.614.
[31] A common genetic defect in nicotine metamolism decreases smoking. Proceeding of the
addicted to nicotine. A National Research Forum. Natcher Conference Center National
Institutes of Health; 1998 July 27-28; Bethesda. Maryland. EE.UU. Disponible en URL:
http://www.nida.nih.gov/meetsum/nicotine/Nicotine.html
[32] Agentes que actúan a nivel de la unión neuromuscular y los ganglios autónomos. En:
Goodman & Gilman's, eds. Las bases farmacológicas de la terapéutica (8.a ed). Buenos Aires:
Editorial Médica Panamericana, SA,1991; 176-195.
[33] Cigarette smoking: the need for action by health professionals. CA Cancer J Clin 1988;
38:194-212.
[36] Nicotine and the central nervous system: biobehavioral effects of cigarette smoking. Am J
Med 1992; 93:2S-7S,
[37] Platelet sensibility to prostacyclin in smokers and non-smokers. Chest 1986; 90:34-38.
[38] Smokeless tobacco and nicotine bring about excessive cytokine responses of murine
memory T-cells. Int J Immunopharmacol 1999; 21:103-114.
[41] The natural history of chronic bronchitis and emphysema. Oxford: Oxford University Press,
1976.
[42] Smoking and its effects on body weight and the systems of caloric regulation. Am J Clin
Nutr 1982; 35:366-380.
[43] The genetic epidemiology of somoking. Proceeding of the addicted to nicotine. A National
Research Forum. Natcher Conference Center National Institutes of Health; 1998 July 27-28;
Bethesda. Maryland. EE.UU. Disponible en URL: http://www.
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 18/19
12/4/24, 4:39 Farmacología de la nicotina | Medicina Integral
[46] Production of endpthelin by culture human endothelial cells following exposure tp nicotine
and caffeine. Metabolism 1999; 48:845-848.
[47] Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison
with cigarettes and nicotine gum. Clin Pharmacol Ther 1988; 44:23-28.
[48] Individual differences in smoking and nicotine addiction. Proceeding of the addicted to
nicotine. A National Research Forum. Natcher Conference Center National Institutes of
Health; 1998 July 27-28; Bethesda. Maryland. EE.UU. Disponible en URL:
http://www.nida.nih.gov/meetsum/nicotine/Nicotine.html
[49] A pharmacologic strategy for the treatment of nicotine addiction. Synapse 1999; 31:76-86.
[50] Mechanism of nicotine dependence. Nihon Arukoru Yakubutsu Igakkai Zasshi 1998; 33:557-
573.
[51] The neurobiology of tobacco addiction. Trends Pharmacol Sci 1991; 12:467-473.
[53] Signs and symptomsmof tobacco withdrawal. Arch Gen Psychiatry 1986; 43:289-294.
[54] Nicotine addiction: implications for public health policy. J Spc Issues 1997; 53:13-33.
[55] The wrong way to stay slim. N Eng J Med 1995; 333:1.214-1.216
es | en | pt
¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?
https://www.elsevier.es/es-revista-medicina-integral-63-articulo-farmacologia-nicotina-11678 19/19